<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37138595</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Amino acid variation at VP1-145 of enterovirus A71 determines the viral infectivity and receptor usage in a primary human intestinal model.</ArticleTitle><Pagination><StartPage>1045587</StartPage><MedlinePgn>1045587</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1045587</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2023.1045587</ELocationID><Abstract><AbstractText Label="UNLABELLED">Enterovirus A71 (EV-A71) can elicit a wide variety of human diseases such as hand, foot, and mouth disease and severe or fatal neurological complications. It is not clearly understood what determines the virulence and fitness of EV-A71. It has been observed that amino acid changes in the receptor binding protein, VP1, resulting in viral binding to heparan sulfate proteoglycans (HSPGs) may be important for the ability of EV-A71 to infect neuronal tissue. In this study, we identified that the presence of glutamine, as opposed to glutamic acid, at VP1-145 is key for viral infection in a 2D human fetal intestinal model, consistent with previous findings in an airway organoid model. Moreover, pre-treatment of EV-A71 particles with low molecular weight heparin to block HSPG-binding significantly reduced the infectivity of two clinical EV-A71 isolates and viral mutants carrying glutamine at VP1-145. Our data indicates that mutations in VP1 leading to HSPG-binding enhances viral replication in the human gut. These mutations resulting in increased production of viral particles at the primary replication site could lead to a higher risk of subsequent neuroinfection.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">With the near eradication of polio worldwide, polio-like illness (as is increasingly caused by EV-A71 infections) is of emerging concern. EV-A71 is indeed the most neurotropic enterovirus that poses a major threat globally to public health and specifically in infants and young children. Our findings will contribute to the understanding of the virulence and the pathogenicity of this virus. Further, our data also supports the identification of potential therapeutic targets against severe EV-A71 infection especially among infants and young children. Furthermore, our work highlights the key role of HSPG-binding mutations in the disease outcome of EV-A71. Additionally, EV-A71 is not able to infect the gut (the primary replication site in humans) in traditionally used animal models. Thus, our research highlights the need for human-based models to study human viral infections.Graphical Abstract.</AbstractText><CopyrightInformation>Copyright © 2023 Aknouch, García-Rodríguez, Giugliano, Calitz, Koen, van Eijk, Johannessson, Rebers, Brouwer, Muncan, Stittelaar, Pajkrt, Wolthers and Sridhar.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aknouch</LastName><ForeName>Ikrame</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Viroclinics Xplore, Schaijk, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García-Rodríguez</LastName><ForeName>Inés</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giugliano</LastName><ForeName>Francesca Paola</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Tytgat Institute for Intestinal and Liver Research, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calitz</LastName><ForeName>Carlemi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koen</LastName><ForeName>Gerrit</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Eijk</LastName><ForeName>Hetty</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johannessson</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebers</LastName><ForeName>Sjoerd</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouwer</LastName><ForeName>Lieke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muncan</LastName><ForeName>Vanesa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Tytgat Institute for Intestinal and Liver Research, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stittelaar</LastName><ForeName>Koert J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Bioinformatics and Animal Models, Wageningen Bioveterinary Research, Wageningen University, Wageningen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pajkrt</LastName><ForeName>Dasja</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolthers</LastName><ForeName>Katja C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sridhar</LastName><ForeName>Adithya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV-A71</Keyword><Keyword MajorTopicYN="N">Transwell</Keyword><Keyword MajorTopicYN="N">VP1-145</Keyword><Keyword MajorTopicYN="N">heparin sulfate proteoglycan</Keyword><Keyword MajorTopicYN="N">human inestinal organoids</Keyword><Keyword MajorTopicYN="N">polarized epithelium</Keyword></KeywordList><CoiStatement>IA is employee of Viroclinics Xplore. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>2</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37138595</ArticleId><ArticleId IdType="pmc">PMC10149690</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2023.1045587</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aknouch I., Sridhar A., Freeze E., Giugliano F. P., van Keulen B. J., Romijn M., et al. . (2022). Human milk inhibits some enveloped virus infections, including SARS-CoV-2, in an intestinal model. Life Sci. Allian. 5:e202201432. doi: 10.26508/lsa.202201432, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202201432</ArticleId><ArticleId IdType="pmc">PMC9354649</ArticleId><ArticleId IdType="pubmed">35926873</ArticleId></ArticleIdList></Reference><Reference><Citation>Boom R., Sol C., Wertheim-van Dillen P. (1990). Rapid purification of ribosomal RNAs from neutral agarose gels. Nucleic Acids Res. 18:2195. doi: 10.1093/nar/18.8.2195, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/18.8.2195</ArticleId><ArticleId IdType="pmc">PMC330721</ArticleId><ArticleId IdType="pubmed">2336409</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes A. P., Griffin D. E. (2000). Large-plaque mutants of sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation. J. Virol. 74, 644–651. doi: 10.1128/JVI.74.2.644-651.2000, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.2.644-651.2000</ArticleId><ArticleId IdType="pmc">PMC111583</ArticleId><ArticleId IdType="pubmed">10623725</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagno V., Donalisio M., Bugatti A., Civra A., Cavalli R., Ranucci E., et al. . (2015). The agmatine-containing poly(amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses. Antimicrob. Agents Chemother. 59, 5250–5259. doi: 10.1128/AAC.00443-15, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00443-15</ArticleId><ArticleId IdType="pmc">PMC4538463</ArticleId><ArticleId IdType="pubmed">26077258</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlucci M., Scolaro L., Noseda M., Cerezo A., Damonte E. (2004). Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice. Antivir. Res. 64, 137–141. doi: 10.1016/j.antiviral.2004.07.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2004.07.001</ArticleId><ArticleId IdType="pubmed">15498610</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S. C., Li W. C., Chen G. W., Tsao K. C., Huang C. G., Huang Y. C., et al. . (2012). Genetic characterization of enterovirus 71 isolated from patients with severe disease by comparative analysis of complete genomes. J. Med. Virol. 84, 931–939. doi: 10.1002/jmv.23287, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23287</ArticleId><ArticleId IdType="pubmed">22499017</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua B. H., Phuektes P., Sanders S. A., Nicholls P. K., McMinn P. C. (2008). The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 89, 1622–1632. doi: 10.1099/vir.0.83676-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83676-0</ArticleId><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>du N., Cong H., Tian H., Zhang H., Zhang W., Song L., et al. . (2014). Cell surface vimentin is an attachment receptor for enterovirus 71. J. Virol. 88, 5816–5833. doi: 10.1128/JVI.03826-13, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K., Sudaka Y., Takashino A., Kobayashi K., Kataoka C., Suzuki T., et al. . (2018). VP1 amino acid residue 145 of enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during Cynomolgus monkey infection. J. Virol. 92:e00682-18. doi: 10.1128/JVI.00682-18, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00682-18</ArticleId><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>García-Rodríguez I., Sridhar A., Pajkrt D., Wolthers K. C. (2020). Put some guts into it: intestinal organoid models to study viral infection. Viruses 12:1288. doi: 10.3390/v12111288, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12111288</ArticleId><ArticleId IdType="pmc">PMC7697248</ArticleId><ArticleId IdType="pubmed">33187072</ArticleId></ArticleIdList></Reference><Reference><Citation>García-Rodríguez I., van Eijk H., Koen G., Pajkrt D., Sridhar A., Wolthers K. C. (2021). Parechovirus a infection of the intestinal epithelium: differences between genotypes A1 and A3. Front. Cell. Infect. Microbiol. 11:740662. doi: 10.3389/fcimb.2021.740662, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.740662</ArticleId><ArticleId IdType="pmc">PMC8591172</ArticleId><ArticleId IdType="pubmed">34790587</ArticleId></ArticleIdList></Reference><Reference><Citation>Good C., Wells A. I., Coyne C. B. (2019). Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci. Adv. 5:eaau4255. doi: 10.1126/sciadv.aau4255, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau4255</ArticleId><ArticleId IdType="pmc">PMC6402847</ArticleId><ArticleId IdType="pubmed">30854425</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S. W., Wang Y. F., Yu C. K., Su I. J., Wang J. R. (2012). Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology 422, 132–143. doi: 10.1016/j.virol.2011.10.015, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka C., Suzuki T., Kotani O., Iwata-Yoshikawa N., Nagata N., Ami Y., et al. . (2015). The role of VP1 amino acid residue 145 of enterovirus 71 in viral fitness and pathogenesis in a Cynomolgus monkey model. PLoS Pathog. 11:e1005033. doi: 10.1371/journal.ppat.1005033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005033</ArticleId><ArticleId IdType="pmc">PMC4504482</ArticleId><ArticleId IdType="pubmed">26181772</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Zou Q., Chen L., Zhang H., Wang Y. (2011). Molecular analysis of virulent determinants of enterovirus 71. PLoS One 6:e26237. doi: 10.1371/journal.pone.0026237, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026237</ArticleId><ArticleId IdType="pmc">PMC3198388</ArticleId><ArticleId IdType="pubmed">22039449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T. Y., Chang L. Y., Hsia S. H., Huang Y. C., Chiu C. H., Hsueh C., et al. . (2002). The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis. 34, S52–S57. doi: 10.1086/338819, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/338819</ArticleId><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindahl U. (2007). Heparan sulfate-protein interactions: a concept for drug design? Thromb. Haemost. 98, 109–115. doi: 10.1160/TH07-04-0310</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH07-04-0310</ArticleId><ArticleId IdType="pubmed">17598000</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. (2009). Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 15, 794–797. doi: 10.1038/nm.1961</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix W. A., Oberste M. S., Pallansch M. A. (2006). Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J. Clin. Microbiol. 44, 2698–2704. doi: 10.1128/JCM.00542-06, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00542-06</ArticleId><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M. H., Wong S. C., Lewthwaite P., Cardosa M. J., Solomon T. (2010). Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 9, 1097–1105. doi: 10.1016/S1474-4422(10)70209-X, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshiro M., Ono K., Suzuki Y., Ota H., Katsuyama T., Mori N. (2001). Immunohistochemical localization of heparan sulfate proteoglycan in human gastrointestinal tract. Histochem. Cell Biol. 115, 373–380. doi: 10.1007/s004180100271, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004180100271</ArticleId><ArticleId IdType="pubmed">11449885</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed L. J., Muench H. (1938). A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493–497. doi: 10.1093/oxfordjournals.aje.a118408</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference><Reference><Citation>Roodsant T., Navis M., Aknouch I., Renes I. B., van Elburg R. M., Pajkrt D., et al. . (2020). A human 2D primary organoid-derived epithelial monolayer model to study host-pathogen interaction in the small intestine. Front. Cell. Infect. Microbiol. 10:10. doi: 10.3389/fcimb.2020.00272</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00272</ArticleId><ArticleId IdType="pmc">PMC7326037</ArticleId><ArticleId IdType="pubmed">32656095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu W. S., Kang B., Hong J., Hwang S., Kim A., Kim J., et al. . (2010). Enterovirus 71 infection with central nervous system involvement, South Korea. Emerg. Infect. Dis. 16, 1764–1766. doi: 10.3201/eid1611.100104, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1611.100104</ArticleId><ArticleId IdType="pmc">PMC3294506</ArticleId><ArticleId IdType="pubmed">21029539</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T., Vries R. G., Snippert H. J., van de Wetering M., Barker N., Stange D. E., et al. . (2009). Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262–265. doi: 10.1038/nature07935, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07935</ArticleId><ArticleId IdType="pubmed">19329995</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M. J., McMinn P., Ooi M. H. (2010). Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10, 778–790. doi: 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar A., Simmini S., Ribeiro C. M. S., Tapparel C., Evers M. M., Pajkrt D., et al. . (2020). A perspective on organoids for virology research. Viruses 12:1341. doi: 10.3390/v12111341, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12111341</ArticleId><ArticleId IdType="pmc">PMC7700289</ArticleId><ArticleId IdType="pubmed">33238561</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P. Y., Liu Y. T., Chang H. Y., Huang S. W., Wang Y. F., Yu C. K., et al. . (2012). Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells. BMC Microbiol. 12:12. doi: 10.1186/1471-2180-12-162</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-12-162</ArticleId><ArticleId IdType="pmc">PMC3478995</ArticleId><ArticleId IdType="pubmed">22853823</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P. Y., Wang Y. F., Huang S. W., Lo Y. C., Wang Y. H., Wu S. R., et al. . (2015). Cell surface Nucleolin facilitates enterovirus 71 binding and infection. J. Virol. 89, 4527–4538. doi: 10.1128/JVI.03498-14, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C. W., Poh C. L., Sam I. C., Chan Y. F. (2013). Enterovirus 71 uses cell surface Heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 87, 611–620. doi: 10.1128/JVI.02226-12, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C. W., Sam I. C., Lee V. S., Wong H. V., Chan Y. F. (2017). VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology 501, 79–87. doi: 10.1016/j.virol.2016.11.009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseligka E. D., Sobo K., Stoppini L., Cagno V., Abdul F., Piuz I., et al. . (2018). A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism. PLoS Pathog. 14:e1007190. doi: 10.1371/journal.ppat.1007190, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007190</ArticleId><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="pubmed">30075025</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sanden S. M. G., Sachs N., Koekkoek S. M., Koen G., Pajkrt D., Clevers H., et al. . (2018). Enterovirus 71 infection of human airway organoids reveals VP1-145 as a viral infectivity determinant. Emerg. Microb. Infect. 7, 1–9. doi: 10.1038/s41426-018-0077-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0077-2</ArticleId><ArticleId IdType="pmc">PMC5943241</ArticleId><ArticleId IdType="pubmed">29743570</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Morigen M. (2014). The genetic control of mouse coat color and its applications in genetics teaching. Yi Chuan 36, 1062–1068. doi: 10.3724/SP.J.1005.2014.1062, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3724/SP.J.1005.2014.1062</ArticleId><ArticleId IdType="pubmed">25406255</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., et al. . (2009). Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15, 798–801. doi: 10.1038/nm.1992, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Ren L., Xiong Z., Li J., Xiao Y., Zhao R., et al. . (2009). Enterovirus 71 outbreak in the People’s Republic of China in 2008. J. Clin. Microbiol. 47, 2351–2352. doi: 10.1128/JCM.00563-09, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00563-09</ArticleId><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Solakyildirim K., Chang Y., Linhardt R. J. (2011). Hyphenated techniques for the analysis of heparin and heparan sulfate. Anal. Bioanal. Chem. 399, 541–557. doi: 10.1007/s00216-010-4117-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-010-4117-6</ArticleId><ArticleId IdType="pmc">PMC3235348</ArticleId><ArticleId IdType="pubmed">20853165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Wu X., Huang K., Li L., Zheng L., Wan C., et al. . (2014). The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection. BMC Infect. Dis. 14:14. doi: 10.1186/1471-2334-14-243</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-243</ArticleId><ArticleId IdType="pmc">PMC4101859</ArticleId><ArticleId IdType="pubmed">24886383</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>